Author:
Grulke N,Albani C,Bailer H
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference64 articles.
1. Aaronson NK, Ahmedzai S, Bergmann B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.
2. Efficace F, Bottomley A, Coens C . Which is the most frequently used health-related quality of life (HRQOL) measure in cancer clinical trials? (abstract). Psychooncology 2006; 15 (2 (Suppl)): S135–S136.
3. Küchler T, Behrend M . Der onkologische Patient—Lebensqualität und supportive Therapie. Im Focus Onkologie 2001; 4: 49–52.
4. Fayers P, Bottomley A . Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 2002; 38 (Suppl 4): S125–S133.
5. Velikova G, Weis J, Hjermstad MJ, Kopp M, Morris P, Watson M et al. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Eur J Cancer 2007; 43: 87–94.